Article

Epigenetic contributions to clinical risk prediction of cardiovascular disease

2022-10-22

Abstract excerpt

<h4>Background and Aims</h4> Cardiovascular disease (CVD) is among the leading causes of death worldwide. Discovery of new omics biomarkers could help to improve risk stratification algorithms and expand our understanding of molecular pathways contributing to the disease. Here, ASSIGN – a cardiovascular risk prediction tool recommended for use in Scotland – was examined in tandem with epigenetic and proteomic feat...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c4316f4f-fe9e-5e57-bf11-1d901a5ef30d
DOI: 10.1101/2022.10.21.22281355

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Epigenetic contributions to clinical risk prediction of cardiovascular diseaseDOI 10.1101/2022.10.21.22281355Read

Epigenetic Contributions to Clinical Risk Prediction of Cardiovascular DiseaseSemantic proximity Read

Epigenetic scores for the circulating proteome as tools for disease predictionSemantic proximity Read

Untargeted Proteomic Profiling Identifies Candidate Biomarkers for Early Detection of Cardiovascular Disease and MortalitySemantic proximity Read

Sex-specific proteomic signatures improve cardiovascular risk prediction for the general population without cardiovascular disease or diabetesSemantic proximity Read

Advancing cardiovascular disease risk prediction beyond conventional methods: a systematic review of multimodal machine learning models integrating traditional clinical factors and multi-omics dataSemantic proximity Read

Circulating cardiovascular proteomic associations with genetics and diseaseSemantic proximity Read

DNAm scores for serum GDF15 and NT-proBNP levels associate with a range of traits affecting the body and brainSemantic proximity Read

Epigenetic Modifications as Predictive Biomarkers for Cardiovascular Disease: A Longitudinal Study on DNA Methylation Patterns and Disease RiskSemantic proximity Read

A blood DNA methylation biomarker for predicting short-term risk of cardiovascular eventsSemantic proximity Read

Integrative analysis of the plasma proteome and polygenic risk of cardiometabolic diseasesSemantic proximity Read

Large-scale evaluation of proteomic and polygenic risk scores reveals complementary contributions to incident disease predictionSemantic proximity Read

Proteomic Profiling of Early-Stage Heart Failure Identifies Candidate Biomarkers and Molecular Pathways of Cardiac Inflammation in the Project Baseline Health StudySemantic proximity Read